EU Call for Projects: Blockchain Enabled Healthcare

The project will initially establish an effective governance organisation and approach to enable continuous improvement and open competition among service providers, while ensuring that critical factors such as data integrity, privacy, regulatory compliance and efficiency are built into a ‘Healthcare Foundation’ which serves as an integration layer between underlying blockchain technologies and the business application layer.
Applications are closed

The pharmaceutical value chain and the extended healthcare ecosystem have many areas that suffer from complexity, a lack of transparency, coordination and trust.

Examples include:

  • counterfeit medicines market estimated at EUR 160 billion with a huge impact on patient health;
  • lack of access to medicines, especially in developing countries, impacting patient health;
  • data accessibility leading to lost opportunities for improved research and new innovative medicines;
  • patient privacy considerations (patient consent) hindering clinical trial recruitment and execution;
  • lack of visibility and shared ’source of truth’ leading to friction and costs in development and distribution;
  • increasing risk of cyber threats, especially with central data storage and sharing.

By addressing these challenges through a public-private consortium, the evaluation, design, and accelerated adoption of blockchain-enabled healthcare solutions across the industry can be fostered. This will facilitate the delivery of true innovation benefiting both patients and the industry.


The overall objective of the agile project generated by this topic is to establish a common blockchain ecosystem for pharmaceutical development, manufacturing, and distribution that provides an incentive and serves as the basis for all participants to engage, adopt, and benefit from.

The project will initially establish an effective governance organisation and approach to enable continuous improvement and open competition among service providers, while ensuring that critical factors such as data integrity, privacy, regulatory compliance and efficiency are built into a ‘Healthcare Foundation’ which serves as an integration layer between underlying blockchain technologies and the business application layer (see architecture diagram).

The project aims to drive the agile delivery of use cases prioritised by clearly defined business value, benefits (return on investment, ROI) and feasibility. Use cases fall into the domains of supply chain, focusing on supply chain integrity and efficiency; clinical development, focusing on clinical trials and submission; and health data, which among others should enable blockchain-based machine learning data marketplaces. A likely focus for prioritised delivery is enabling end-to-end product tracking with blockchain technology to address the issue of counterfeit medicines, taking into account existing initiatives such as the proposed European Medicines Verification System. The project will also evaluate the use of medical devices across multiple use cases in order to ensure the integrity of device, data and services to enable the benefits of the internet of things (IoT). The initial technology deliverable is an architectural framework enabling such factors as digital identity management, efficient consensus mechanism, off-chain storage, global scalability, security, and high performance. Other use cases can be added based on a value analysis during the project lifetime and proposals from the selected applicant consortium. The scope includes a reference implementation of the solution but does not include specific industry partner implementations.

Expected Impact:

The project generated by this topic will generally position the industry as a leader in innovation and serve to improve the overall trust and reputation of participants. Full realisation of the envisioned benefits will require a transformation of many core processes in organisations over several years beyond the life of the project. The project will establish a strong foundation to enable these benefits in accelerated manner. Envisioned long term benefits include:

  • Patients will have earlier access to both the medicines they need and information on drug provenance; this will improve overall transparency, and with it trust in and the reputation of the industry. The supply chain will be more secure through anti-counterfeiting measures, building on the solutions designed to fulfil the Falsified Medicines Directive (FMD). The project will evaluate and define additional potential patient-centric services.
  • Permissioned and secure healthcare data sharing will be enabled between patients, healthcare providers, researchers and other stakeholders. Patients will have full control of their health data and be able to join clinical, sensor and behavioural data into a self-sovereign 360 degree health record. Patients will be able to donate data or grant access to their data for a defined / limited time or purpose to research and real world registries in a trusted and anonymous manner. If seeking information on clinical trials, patients will have recommendations made to them based on their health profiles.
  • Healthcare providers will use limited resources more efficiently by streamlining clinical trials and eliminating expenses for counterfeit and substandard medicines. Automation of processes and reliability of data will enable significant improvements to the current status quo.
  • The pharmaceutical industry will benefit from widely accepted standards and demonstrated actions to ensure the integrity of drug development and distribution to the patient. Accelerated adoption of digital technology will additionally result in efficiencies across the industry with improved transparency, visibility and availability of drugs to the market. It can also better position the industry for new innovative therapies relying on the patient’s own cells (chain of identity).
  • The applicant consortium will benefit from investments in research programmes and early adoption of innovative solutions.
  • Applicants should indicate how their proposal will impact the competitiveness and industrial leadership of Europe by, for example engaging suitable SMEs.
Dateline for submission: 24 October 2018 17:00:00 (Brussels time)
Source: The European Commission

Illustration Photo: a drugstore (credits: PressReleaseFinder / Flickr Creative Commons Attribution-NonCommercial-NoDerivs 2.0 Generic (CC BY-NC-ND 2.0))

Read more


No comments to display.

Related posts

Hadron Therapy Industry 2019-2025: Global Size, Share, Emerging Trends, Demand, Revenue and Forecasts Research

Hadron Therapy Industry 2019 Global Market research report studies latest Hadron Therapy industry aspects market size, share, trends, growth, business overview and Hadron Therapy industry scenario during the forecast period (2019-2025).

Acid Catalysts Industry 2019: Global Market Size, Growth, Share, Insights, Supply, Drivers, Demand, Outlook, Trends and Forecasts 2025

A latest report has been added to the wide database of Orian Research Consultant titled “Global Acid Catalysts Market Research Report (2025)” which provides an outlook of current market value, Size, Share, Growth, Trends and Forecast.
3 days ago

Continuous Renal Replacement Therapy Industry 2019 Global Market Size, Share, Growth, Sales and Drivers Analysis Research Report 2025

Continuous Renal Replacement Therapy Industry 2019 Global Market Research report provides information regarding market size, share, trends, growth, cost structure, capacity, and revenue and forecast 2025.

Black Pellets Industry 2019 Global Market Size, Outlook, Demand, Key Manufacturers and 2025 Forecast

A recent market report published on the “Black Pellets Industry” presents an in-depth overview of the Black Pellets industry. Global Black Pellets market research report covers the overview, summary, Black Pellets market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. Apart from this, the Black Pellets report also covers detail information about various clients which is the most significant element for the manufacturers.
3 days ago

Call for Applications: Startup World Cup 2019

Startup World Cup ("SWC") offers innovation and entrepreneurship opportunities for startup ecosystems around the world. This platform consists of a global series of startup conferences and competitions that bring together phenomenal startups, VCs, and world-class tech CEOs.
Application Deadline in 2 months

EU Call for Proposals: Information and promotion about the sustainable aspect of rice production

The objective is to highlight the sustainable aspect of rice sector. Rice production in Europe has a particular environmental dimension, being at the heart of the preservation of certain wetlands. Rice cultivation is a sensitive and specific practice at European level, since it is produced in areas where there are few crop alternatives. Its preservation and improvement contribute to the sustainability of rice producing regions, by playing an active role in maintaining rural areas, protecting nature and preserving biodiversity. Actions shall highlight the environmental sustainability of the production, stressing its beneficial role for climate action and the environment.
Application Deadline in 22 days

A low-cost and open-source platform for automated imaging

Remote monitoring of plants using hyperspectral imaging has become an important tool for the study of plant growth, development, and physiology. Many applications are oriented towards use in field environments to enable non-destructive analysis of crop responses due to factors such as drought, nutrient deficiency, and disease, e.g., using tram, drone, or airplane mounted instruments.

Can developing nations compete in a digital world?

People want in on e-commerce for simple reasons - choice, ease, speed, cost, convenience. Yet not everyone benefits equally, especially in least developed countries.